EUVIMEDEUVIMED entdecken
Crossref

AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2/HIF-1α positive feedback loop

Wenliang Lu, Wei Wang, Bo Chen, Ziming Huang, Ran Jiang

Biochemical and Biophysical Research Communications · 2026

DOI: 10.1016/j.bbrc.2026.154365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Wenliang Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei Province, 430070, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Triple Negative Breast Neoplasms, Glycolysis, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Triple-negative breast cancer (TNBC) displays aggressive progression and pronounced hypoxia-driven metabolic remodeling. However, whether the long non-coding RNA AC137932.2 mechanistically links hypoxia signaling to glycolysis in TNBC through maintenance of HIF-1α output remains unclear. METHODS: TCGA-BRCA data were used to analyze AC137932.2 expression, its prognostic value, and its correlation with glycolysis-related genes and VEGFA. AC137932.2 levels were measured in breast cancer cell lines and hypoxia-treated TNBC cells via qRT‒PCR. Loss-of-function and rescue assays were performed in MDA-MB-231 and BT-549 cells. Cell viability, EdU incorporation, invasion, ATP content, glucose consumption, lactate production, extracellular acidification rate (ECAR), glycolysis, and glycolytic capacity were examined. RIP-qPCR, actinomycin D chase, dual-luciferase reporter, and ChIP‒qPCR assays were used to clarify the AC137932.2/IGF2BP2/HIF-1α mechanism. RESULTS: AC137932.2 was upregulated in breast cancer tissues and TNBC cells, was associated with poor prognosis, and was positively correlated with glycolysis-related genes and VEGFA. Hypoxia induced AC137932.2 expression in MDA-MB-231 and BT-549 cells. AC137932.2 knockdown suppressed TNBC cell viability, proliferation, invasion, ATP production, glucose consumption, lactate production, the ECAR, glycolysis, and glycolytic capacity under both normoxia and hypoxia. Mechanistically, AC137932.2 was mainly localized in the cytoplasm and interacted with IGF2BP2. AC137932.2 stabilized HIF-1α mRNA through IGF2BP2, while HIF-1α bound to the AC137932.2 promoter and activated its transcription. IGF2BP2 or HIF-1α overexpression partially rescued the inhibitory effects of AC137932.2 knockdown on TNBC malignancy and glycolysis. CONCLUSION: AC137932.2 promotes TNBC proliferation, invasion, and glycolytic reprogramming by forming an AC137932.2/IGF2BP2/HIF-1α positive feedback loop, suggesting that this axis may be a potential therapeutic target for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitTriple Negative Breast NeoplasmsGlycolysisRNA-Binding ProteinsRNA, Long NoncodingHumansFemaleCell Line, TumorGene Expression Regulation, NeoplasticFeedback, PhysiologicalMDA-MB-231 CellsMetabolic Reprogramming

Stichwörter der Autor:innen

AC137932.2GlycolysisHIF-1αHypoxiaIGF2BP2Triple-negative breast cancer

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitRNA-Binding ProteinsRNA, Long NoncodingIGF2BP2 protein, humanHIF1A protein, human

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei Province, 430070, China.
  • Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for…
  • Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei Province, 430070, China. Electronic address: jiangransfy@outlook.com.

Zitieren

APA

Lu, W., Wang, W., Chen, B., Huang, Z., & Jiang, R. (2026). AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2/HIF-1α positive feedback loop. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.154365

Vancouver

Lu W, Wang W, Chen B, Huang Z, Jiang R. AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2/HIF-1α positive feedback loop. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.154365

BibTeX
@article{Lu2026,
  author = {Lu, Wenliang and Wang, Wei and Chen, Bo and Huang, Ziming and Jiang, Ran},
  title = {AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2/HIF-1α positive feedback loop},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  doi = {10.1016/j.bbrc.2026.154365}
}
Kostenlos starten →